Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Blocking LFA-1 prevents hair loss in mice.

Entospletinib effectively prevents eye and skin GVHD in mice.

New cytokine-targeted therapies show promise for treating alopecia areata.

PTH-CBD agonists may help regrow hair after chemotherapy.

Six existing drugs may help block virus entry in COVID-19.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

JAK inhibitors are effective treatments for alopecia areata.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Five FDA-approved drugs may help block COVID-19 virus entry.

Basal cell carcinomas may use IDO to protect themselves from the immune system.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Topical IKKα inhibitors may help prevent CCS tumours.